From the clinical point of view, upregulated FOXO-1 raises a state of insulin resistance and diabetes, due to a loss of insulin sensitivity, and the consequent hyperglycemia or high glucose accelerates cellular damage [31]. Here, INS is linked to diabetes mellitus.